Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-34,528
Closed -$1.31M 1799
2026
Q1
$1.31M Buy
+34,528
New +$1.28M 0.01% 919
2025
Q3
Sell
-20,652
Closed -$577K 1759
2025
Q2
$577K Sell
20,652
-191,248
-90% -$4.96M 0.01% 1115
2025
Q1
$5.58M Buy
211,900
+186,928
+749% +$4.66M 0.06% 375
2024
Q4
$639K Sell
24,972
-42,025
-63% -$988K ﹤0.01% 1083
2024
Q3
$1.37M Buy
+66,997
New +$1.32M 0.01% 866
2024
Q2
Sell
-31,075
Closed -$502K 1724
2024
Q1
$502K Buy
+31,075
New +$472K ﹤0.01% 1140
2023
Q3
Sell
-14,728
Closed -$250K 1899
2023
Q2
$250K Buy
+14,728
New +$279K ﹤0.01% 1615
2020
Q1
Sell
-30,857
Closed -$630K 1340
2019
Q4
$630K Buy
+30,857
New +$659K 0.01% 744

Other funds holding IMAX

Michael Gelband's IMAX Position: Q2 2026 in Review

Michael Gelband sold out of IMAX (IMAX) in Q2 2026, closing a stake of 34,528 shares — an estimated $1.31M sold.

Michael Gelband first reported a position in IMAX in Q4 2019 and held it in 8 quarters. The position peaked at $5.58M in Q1 2025. 255 funds tracked by Wall St. Rank hold IMAX as of Q2 2026.

  • Michael Gelband reported no remaining IMAX position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 34,528 IMAX shares in Q2 2026, an estimated $1.31M.
  • Michael Gelband first reported a position in IMAX in Q4 2019 and held it in 8 quarters.
  • Michael Gelband's IMAX position peaked at $5.58M in Q1 2025.
  • 255 funds tracked by Wall St. Rank held IMAX as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.